Larvol Delta - ATRC101--Pembrolizumab-in-solid-tumors-interim-analysis-with-good-safety-and-some-early-signs-of-efficacy-by-senior-author-benweinbergmd-LombardiCancer-Immunotherapy-SITC22

ATRC-101 - Atreca

Keytruda (pembrolizumab) - Merck (MSD)

https://twitter.com/DrGattiMays/status/1590788857036869632

Nov 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next